RxDoctor Payments Data

Patti Osborne

Family · Ocala, FLNPI 1902117716

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,083 of the $1,225 with a category attached, or 88.4%. It is spread thinly across 22 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $566 and has fallen 75.7% since, to $138 in 2025.

$1,225in general payments, 2019–2025

Across 60 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$252
  • Johnson & Johnson$227
  • Seagen Inc.$143
  • Lilly USA, LLC$132
  • Amgen$75
  • Octapharma USA, Inc.$53
  • plus $343 from 16 others

What the payments were for

  • Food & beverage$1,08388%
  • Education$14212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,225 in reported general payments places this provider in the 70th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Ocala

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →